# Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.

> **NCT06409767** · NA · RECRUITING · sponsor: **University Hospital, Angers** · enrollment: 2224 (estimated)

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma

## Interventions

- **OTHER:** Real-time calculation of the NEWS with ICU admission if NEWS ≥ 7.

## Key facts

- **NCT ID:** NCT06409767
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2028-04-11
- **Final completion:** 2028-07-11
- **Target enrollment:** 2224 (ESTIMATED)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409767, "Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06409767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*